NovaBay Pharmaceuticals, Inc. Reports 2014 Fourth Quarter And Full Year Financial Results And Provides Business Update

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products for the global eye care market, today reported financial results for the three and 12 months ended December 31, 2014, and provided a business update.

Help employers find you! Check out all the jobs and post your resume.